サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1756442

微小残存病変検査市場：製品別、技術別、用途別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測

Minimal Residual Disease Testing Market, By Product, By Technology, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 397 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
微小残存病変検査市場：製品別、技術別、用途別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2025年05月15日
発行: AnalystView Market Insights
ページ情報: 英文 397 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

微小残存病変検査市場規模は2024年に14億5,600万米ドルとなり、2024～2032年にかけてCAGR 12.5％で拡大

微小残存病変検査市場-市場力学

個別化医療への需要の高まり

個別化医療に対する需要の高まりは、がん治療や診断を含むさまざまなヘルスケアセグメントにおける重要な推進力となっています。個別化医療は、遺伝的、環境的、ライフスタイル的要因に基づいて個々の患者に合わせた治療を行い、効果を高め、副作用を軽減することに焦点を当てています。この動向は、微小残存病変（MRD）検査のような技術の採用を加速させています。再発リスクの高い患者を特定することで、MRD検査はより的を絞った治療を促進し、転帰を改善します。個別化された治療計画がますます一般的になるにつれ、MRD検査のような先進的診断ツールの市場は拡大し、ヘルスケア専門家に疾患を効果的に管理・治療するためのより良い選択肢を提供すると予想されます。このような個別化医療へのシフトが、関連診断市場の成長を支えています。

微小残存病変検査市場-主要な洞察

当社のリサーチアナリストによると、世界の微小残存病変検査市場は、2024～2032年にかけて約12.5%のCAGRで開発される見込みです。

2024年の製品別セグメントでは、アッセイキット＆試薬カテゴリが市場を独占しています。

技術別では、ポリメラーゼ連鎖反応が2024年に最も収益を上げました。

地域別では、2024年に北米が最も収益を上げた地域でした。

最小残存病変検査市場-セグメンテーション分析

世界の最小残存病変検査市場は5つのカテゴリーに分類されます：製品、技術、用途、エンドユーザー、地域です。

最小残存病変（MRD）検査市場は主に2つのセグメントに分けられます：アッセイキット＆試薬と機器です。アッセイキットと試薬は、MRD検査の実施に不可欠であり、サンプル分析に必要なコンポーネントを提供し、低レベルの最小残存病変の正確な検出を保証します。これらのキットは、費用対効果、使いやすさ、正確な結果をもたらす能力から、高い需要があります。一方、フローサイトメーターやPCR装置などの機器は、MRD検査の実施やサンプルの分析に不可欠です。どちらのセグメントも検査プロセスには欠かせないが、市場を独占しているのはアッセイキットと試薬です。手頃な価格と様々な検査環境への適応性により、臨床診断や調査において好まれています。個別化医療の成長は、これらの製品に対する需要の増加をさらに後押ししています。

MRD検査市場は、技術別にポリメラーゼ連鎖反応（PCR）、次世代シーケンス（NGS）、フローサイトメトリー、その他の技術に区分されます。ポリメラーゼ連鎖反応（PCR）は、特定のDNA配列を増幅する能力により広く使用されている技術であり、低レベルの残存疾患を高感度で検出することができます。次世代シーケンス（NGS）は、より先進的技術であり、詳細なシーケンス能力を提供し、遺伝子変異に関する詳細な洞察を提供し、最小限の疾患の検出に役立ちます。フローサイトメトリーは、蛍光標識抗体を用いて特定の細胞タイプを同定・定量するもので、血液サンプル中の異常細胞や残存細胞の同定に極めて重要な役割を果たします。どの技術にも大きな利点があるが、ポリメラーゼ連鎖反応（PCR）は、その確立された信頼性、広範な採用、費用対効果により、市場を独占しています。PCR法は、最小残存病変レベルの検出におけるその精度と拡大性により、特に臨床現場でMRD検査に最も好まれる手法であり続けています。

微小残存病変検査市場-地理的洞察

最小残存病変検査市場は、地理的には北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらしている国に基づいてさらに分割されます。

北米では、米国が最小残存病変（MRD）検査市場の支配的な参入企業であり、先進的ヘルスケアインフラ、重要な研究開発活動、最先端技術の高い採用率がその原動力となっています。米国は個別化医療と分子診断のセグメントでリードしており、主要ヘルスケア機関とバイオテクノロジー企業がMRD検査技術に投資しています。カナダは、強力なヘルスケア施策と整備された医療制度の恩恵を受けており、その後に続いています。両国における精密医療と先進的診断ツールに対する需要の高まりが、市場の堅調な成長を支えています。

欧州では、ドイツがMRD検査の主要市場として際立っているが、これはその強力なヘルスケアシステム、バイオテクノロジーへの多額の投資、確立された研究機関のおかげです。ドイツは精密医療と疾患の早期発見に重点を置いており、MRD検査の採用を後押ししています。英国も有力な参入企業であり、医療部門に潤沢な資金が投入され、先進的診断薬に対する需要が高いです。英国は研究や臨床検査に積極的に参加しており、微小残存病変に対する認識も高まっていることから、欧州におけるMRD検査の重要な市場となっています。

微小残存病変検査市場-競合情勢

微小残存病変（MRD）検査市場の競合力学は、既存ヘルスケア・診断企業と新興イノベーターによって形成されています。F. Hoffmann-La Roche AG、Laboratory Corporation of America Holdings、Guardant Health Inc.などの大手企業は、高い精度と感度を提供する最先端のMRD検査ソリューションで優位を占めています。これらの企業は、診断技術を強化し、規制コンプライアンスを維持するために研究開発に多額の投資を行っています。Adaptive BIoTechnologiesやArcherdxなどの新規参入企業は、次世代シークエンシング（NGS）やリキッドバイオプシーなどの革新的手法に注力し、検出とモニタリングを改善しています。この競合はMRD検査の継続的な進歩を促進し、患者の転帰を向上させています。

目次

第1章 微小残存病変検査市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 微小残存病変検査の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 微小残存病変検査産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 微小残存病変検査市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 微小残存病変検査市場情勢

  • 微小残存病変検査市場シェア分析（2023年）
  • 主要メーカー別内訳データ
    • ベテラン選手の分析
    • 新興企業の分析

第7章 微小残存病変検査市場-製品別

  • 概要
    • 製品別セグメントシェア分析
    • アッセイキット＆試薬
    • 機器

第8章 微小残存病変検査市場-技術別

  • 概要
    • 技術別セグメントシェア分析
    • ポリメラーゼ連鎖反応
    • 次世代シーケンス
    • フローサイトメトリー
    • その他

第9章 微小残留病変検査市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • 造血悪性腫瘍
      • 白血病
      • 骨髄性白血病
      • リンパ性白血病
      • その他の白血病
      • リンパ腫
      • 非ホジキンリンパ腫
      • ホジキンリンパ腫
    • 固形腫瘍
    • 多発性骨髄腫
    • その他

第10章 微小残存病変検査市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院と専門クリニック
    • 診断ラボ
    • 学術研究機関
    • その他

第11章 微小残存病変検査市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-微小残存病変検査産業

  • 競合ダッシュボード
    • Competitive Benchmarking
    • Competitive Positioning
  • 企業プロファイル
    • F. Hoffmann-La Roche AG
    • Laboratory Corporation of America Holdings
    • Guardant Health Inc.
    • Sysmex Corporation
    • Neogenomics Laboratories
    • Molecularmd
    • Adaptive BIoTechnologies
    • Archerdx
    • Bio-Rad Laboratories Inc.
    • Natera, Inc.
    • Opko Health
    • その他

第13章 アナリストの全方位展望

目次
Product Code: ANV5342

REPORT HIGHLIGHT

Minimal Residual Disease Testing Market size was valued at USD 1,456 Million in 2024, expanding at a CAGR of 12.5% from 2024 to 2032.

Minimal Residual Disease (MRD) testing is a diagnostic tool used to detect the presence of residual cancerous cells that remain in a patient after treatment. These cells are often at extremely low levels and are undetectable through traditional imaging or biopsy methods. MRD testing is particularly important in hematologic cancers, such as leukemia and lymphoma, where it helps to identify patients at risk of relapse. By detecting minimal disease levels, MRD testing can guide treatment decisions, monitor disease progression, and help assess the effectiveness of ongoing therapies. It is essential for personalized patient care and improving outcomes.

Minimal Residual Disease Testing Market- Market Dynamics

Increasing Demand for Personalized Medicine

The growing demand for personalized medicine is a significant driver in various healthcare sectors, including cancer treatment and diagnostics. Personalized medicine focuses on tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors, enhancing the effectiveness and reducing adverse effects. This trend has accelerated the adoption of technologies like Minimal Residual Disease (MRD) testing. By identifying patients at high risk for relapse, MRD testing facilitates more targeted therapies, improving outcomes. As personalized treatment plans become increasingly popular, the market for advanced diagnostic tools, such as MRD testing, is expected to expand, offering healthcare professionals better options to manage and treat diseases effectively. This shift towards individualized care supports growth in related diagnostic markets.

Minimal Residual Disease Testing Market- Key Insights

According to our research analyst, the global Minimal Residual Disease Testing Market is expected to develop at a CAGR of approximately 12.5% between 2024-2032.

Segmented by Product in 2024, the Assay Kits & Reagents category dominated the market.

Based on Technology, the Polymerase Chain Reaction generated the most income in 2024.

Based on region, in 2024, North America was the region with the highest revenue.

Minimal Residual Disease Testing Market- Segmentation Analysis:

The global Minimal Residual Disease Testing Market is divided into five categories: Product, Technology, Application, End User and Region.

The Minimal Residual Disease (MRD) testing market is primarily divided into two segments: Assay Kits & Reagents and Instruments. Assay kits and reagents are essential for performing MRD tests, providing the necessary components for sample analysis, and ensuring accurate detection of minimal residual disease at low levels. These kits are in high demand due to their cost-effectiveness, ease of use, and ability to deliver precise results. On the other hand, instruments such as flow cytometers and PCR machines are crucial for executing MRD tests and analyzing the samples. While both segments are critical to the testing process, Assay Kits & Reagents dominate the market. Their affordability and adaptability to various testing environments make them a preferred choice in clinical diagnostics and research. The growth in personalized medicine further supports the increasing demand for these products.

The MRD testing market is segmented by technology into Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Flow Cytometry, and Other Technologies. Polymerase Chain Reaction (PCR) is a widely used technology due to its ability to amplify specific DNA sequences, enabling the detection of low levels of residual disease with high sensitivity. Next-Generation Sequencing (NGS) is a more advanced technology that offers deep sequencing capabilities, providing detailed insights into genetic mutations and aiding in detecting minimal disease. Flow Cytometry uses fluorescently labeled antibodies to identify and quantify specific cell types, playing a pivotal role in identifying abnormal or residual cells in blood samples. While all technologies offer significant advantages, Polymerase Chain Reaction (PCR) dominates the market due to its established reliability, widespread adoption, and cost-effectiveness. It remains the most preferred method for MRD testing, especially in clinical settings, due to its precision and scalability in detecting minimal disease levels.

Minimal Residual Disease Testing Market- Geographical Insights

Geographically, the Minimal Residual Disease Testing Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

In North America, the United States is the dominant player in the Minimal Residual Disease (MRD) testing market, driven by advanced healthcare infrastructure, significant research and development activities, and a high adoption rate of cutting-edge technologies. The U.S. leads in personalized medicine and molecular diagnostics, with major healthcare institutions and biotech companies investing in MRD testing technologies. Canada follows closely, benefiting from strong healthcare policies and a well-developed healthcare system. The increasing demand for precision medicine and advanced diagnostic tools in both countries supports robust market growth.

In Europe, Germany stands out as a key market for MRD testing, owing to its strong healthcare system, significant investment in biotechnology, and well-established research institutions. Germany's emphasis on precision medicine and early detection of diseases fuels the adoption of MRD testing. The United Kingdom is another dominant player, with a well-funded healthcare sector and high demand for advanced diagnostics. The UK's active participation in research and clinical trials, along with increasing awareness of minimal residual disease, makes it a critical market for MRD testing within Europe.

Minimal Residual Disease Testing Market- Competitive Landscape:

The competitive dynamics of the Minimal Residual Disease (MRD) Testing market are shaped by both established healthcare and diagnostic players, as well as emerging innovators. Major players like F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, and Guardant Health Inc. dominate with cutting-edge MRD testing solutions, offering high accuracy and sensitivity. These firms invest heavily in R&D to enhance their diagnostic technologies and maintain regulatory compliance. New entrants, such as Adaptive Biotechnologies and Archerdx, focus on innovative methods like next-generation sequencing (NGS) and liquid biopsy, which improve detection and monitoring. This competition fosters continual advancements in MRD testing, enhancing patient outcomes.

Recent Developments:

In April 2025, Guardant Health introduced a significant upgrade to its liquid biopsy platform, enhancing its ability to detect minimal residual disease (MRD) with greater sensitivity. This advancement allows for earlier detection of cancer recurrence, enabling more timely and targeted interventions. The platform's increased sensitivity is particularly beneficial in monitoring patients post-treatment, improving overall patient outcomes.

In July 2024, Roche completed the acquisition of LumiraDx's point-of-care technology, aiming to expand access to diagnostic testing in primary care settings. This acquisition enhances Roche's capabilities in providing decentralized testing solutions, facilitating earlier detection and monitoring of diseases, including MRD, in diverse healthcare environments. The integration of LumiraDx's technology aligns with Roche's strategy to broaden the reach of its diagnostic services globally.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings
  • Guardant Health Inc.
  • Sysmex Corporation
  • Neogenomics Laboratories
  • Molecularmd
  • Adaptive Biotechnologies
  • Archerdx
  • Bio-Rad Laboratories Inc.
  • Natera, Inc.
  • Opko Health x
  • Others

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Assay Kits & Reagents
  • Instruments

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction
  • Next-Generation Sequencing
  • Flow Cytometry
  • Other Technologies

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Hematological Malignancies
  • Leukemia
  • Myeloid Leukemia
  • Lymphocytic Leukemia
  • Other Leukemias
  • Lymphoma
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Solid Tumors
  • Multiple Myeloma
  • Other Applications

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Specialty Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Other End Users

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Minimal Residual Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Minimal Residual Disease Testing Market Snippet by Product
    • 2.1.2. Minimal Residual Disease Testing Market Snippet by Technology
    • 2.1.3. Minimal Residual Disease Testing Market Snippet by Application
    • 2.1.4. Minimal Residual Disease Testing Market Snippet by End User
    • 2.1.5. Minimal Residual Disease Testing Market Snippet by Country
    • 2.1.6. Minimal Residual Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Minimal Residual Disease Testing Key Market Trends

  • 3.1. Minimal Residual Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Minimal Residual Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Minimal Residual Disease Testing Market Opportunities
  • 3.4. Minimal Residual Disease Testing Market Future Trends

4. Minimal Residual Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Minimal Residual Disease Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Minimal Residual Disease Testing Market Landscape

  • 6.1. Minimal Residual Disease Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Minimal Residual Disease Testing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Assay Kits & Reagents
    • 7.1.3. Instruments

8. Minimal Residual Disease Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. Polymerase Chain Reaction
    • 8.1.3. Next-Generation Sequencing
    • 8.1.4. Flow Cytometry
    • 8.1.5. Other Technologies

9. Minimal Residual Disease Testing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Hematological Malignancies
      • 9.1.2.1. Leukemia
      • 9.1.2.1.1. Myeloid Leukemia
      • 9.1.2.1.2. Lymphocytic Leukemia
      • 9.1.2.1.3. Other Leukemias
      • 9.1.2.2. Lymphoma
      • 9.1.2.2.1. Non-Hodgkin Lymphoma
      • 9.1.2.2.2. Hodgkin Lymphoma
    • 9.1.3. Solid Tumors
    • 9.1.4. Multiple Myeloma
    • 9.1.5. Other Applications

10. Minimal Residual Disease Testing Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Hospitals and Specialty Clinics
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Other End Users

11. Minimal Residual Disease Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Minimal Residual Disease Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Minimal Residual Disease Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Minimal Residual Disease Testing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Minimal Residual Disease Testing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Minimal Residual Disease Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Minimal Residual Disease Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. F. Hoffmann-La Roche AG
    • 12.2.2. Laboratory Corporation of America Holdings
    • 12.2.3. Guardant Health Inc.
    • 12.2.4. Sysmex Corporation
    • 12.2.5. Neogenomics Laboratories
    • 12.2.6. Molecularmd
    • 12.2.7. Adaptive Biotechnologies
    • 12.2.8. Archerdx
    • 12.2.9. Bio-Rad Laboratories Inc.
    • 12.2.10. Natera, Inc.
    • 12.2.11. Opko Health
    • 12.2.12. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us